16/02/2021 - 06:53
Bharat Book Bureau Provides the Trending Market Research Report on “United States Self-Monitoring Blood Glucose (SMBG) Market Analysis 2015 - 2020 and Industry Forecast 2021 - 2027”under Life Sciences Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.
The United States Self-Monitoring Blood Glucose Market is anticipated to cross US$ 4.6 billion by the year-end of 2027. Large patient pool suffering from diabetes, the rapid uptake of innovative, user-friendly, and technological advancements products, the surge in the aging population, and an upsurge in risk factors that lead to diabetes drive the growth of the U.S self-monitoring blood glucose market.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The United States market for self-monitoring blood glucose is anticipated to cross US$ 4.6 billion by the year-end of 2027.
Large patient pool suffering from diabetes, the rapid uptake of innovative, user-friendly, and technological advancements products, the surge in the aging population, and an upsurge in risk factors that lead to diabetes drive the growth of the U.S self-monitoring blood glucose market.
Report Scope:
Delivers a Complete Overview of the United States Insulin Users and Forecast to 2027
The United States Self-Monitoring Blood Glucose Market Size and Forecast (2015 - 2027)
The United States Self-Monitoring Blood Glucose Market Share & Y-o-Y Growth (%), 2015 - 2027
tanmayFebruary 13, 2021
United States
Influenza Vaccines Market is based on an inclusive study of the entire United States influenza vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States influenza vaccines market. The study also presents a comprehensive analysis of the market dynamics and estimation of the market size over the forecast period 2020 – 2027.
The United States
The
Major Companies Dominating this Market for its Products, Services, and Continuous Product Developments are:
Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited), AstraZeneca, Novavax, BiondVax Pharmaceuticals Ltd., Medicago, Moderna Inc, Pneumagen, Daiichi Sankyo, Altimmune, FluGen, Imutex and Others.